Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood

DNA methylation biomarkers in circulating cell-free DNA (cfDNA) have great clinical potential for cancer management. Most methods for DNA methylation analysis require bisulfite conversion, causing DNA degradat...

Source: Clinical Epigenetics - September 14, 2023 Category: Research Authors: Stine H. Kresse, Sara Brandt-Winge, Heidi Pharo, Bj ørnar T. B. Flatin, Marine Jeanmougin, Hege Marie Vedeld and Guro E. Lind Tags: Research Source Type: research